The effects of β-estradiol on raf activity, cell cycle progression and growth factor synthesis in the MCF-7 breast cancer cell line

Cancer Biology and Therapy

Volumn 1, Issue 3, 2002, Pages 256-262

  Weinstein Oppenheimer, Caroline R ^a,b   Burrows, Carla ^a   Steelman, Linda S ^a   McCubrey, James A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

Author keywords

A Raf; B Raf; Breast cancer; Cancer therapy; Cell cycle progression; MCF 7; Raf 1; Signal transduction; estradiol

Indexed keywords

A RAF KINASE; AMPHIREGULIN; B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR; GLYCOPROTEIN; GROWTH PROMOTOR; MESSENGER RNA; RAF PROTEIN; SIGNAL PEPTIDE;

ARTICLE; BREAST TUMOR; CELL CULTURE; CELL CYCLE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PATHOLOGY;

BREAST NEOPLASMS; CELL CYCLE; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTO-ONCOGENE PROTEINS A-RAF; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RNA, MESSENGER; SEQUENCE DELETION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0012453190     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.77     Document Type: Article

References (75)

1. Samuels ML, Weber MJ, Bishop JM, McMahon M. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol 1993; 13:6241-52. (Pubitemid 23292618)
2. McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA, et al.Differential abilities of activated Raf oncoproteins to abrogate cytokine-dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells. Leukemia 1998; 12:1903-29. (Pubitemid 28554464)
3. Lau QC, Brusselbach S, Muller R. Abrogation of c-Raf-1 expression induces apoptosis in tumor cells. Oncogene 1998; 16:1899-1902. (Pubitemid 28197410)
4. Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, et al. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs. Leukemia 1999; 13:1109-66. (Pubitemid 29396575)
5. Hoyle PE, Moye PW, Steelman LS, Blalock WL, Franklin RA, Pearce M, et al.Differential abilities of protein kinases to abrogate cytokine-dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism. Leukemia 2000; 14:642-56. (Pubitemid 30195455)
6. Blalock WL, Pearce M, Steelman LS, Franklin RA, McCarthy SA, Cherwinski H, et al. A conditionally-active form of MEK1 abrogates cytokine-dependency in human and mouse hematopoietic cells. Oncogene 2000; 19:526-36. (Pubitemid 30099366)
7. Weinstein-Oppenheimer CR, Blalock WL, Steelman LS, Chang F, McCubrey JA. The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors. Pharmacol Ther 2000; 88:229-79. (Pubitemid 32406054)
8. Blagosklonny MV. Cell death beyond apoptosis. Leukemia 2000; 14:1502-8. (Pubitemid 30601357)
9. Johnson DE. Programmed cell death regulation: basic mechanisms and therapeutic opportunities. Leukemia 2000; 14:1340-4. (Pubitemid 30599312)
10. Callans LS, Naama H, Khandelwal M, Plotkin R, Jardines L. Raf-1 protein expression in human breast cancer cells. Ann Surg Oncol 1995; 2:38-42.
11. Blagosklonny MV, Schulte TW, Nguyen P, Mimnaugh EG, Trepel J, Neckers L. Taxol induction of p21Waf1 and p53 requires c-raf-1. Cancer Res 1995; 55:4623-6.
12. Weinstein-Oppenheimer CR, Henriquez-Roldan CF, Davis JM, Navolanic PM, Saleh OA, Steelman LS, et al.Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin. Clin Cancer Res 2001; 7:2892-907.
13. Johnson DE. Noncaspase proteases in apoptosis. Leukemia 2000; 14:1695-1703.
14. Cornwell MM, Smith AD. signal transduction pathway for activation of the mdr 1 promoter involves the proto-oncogene c-raf kinase. J Biol Chem 1993; 268:15347-50. (Pubitemid 23222019)
15. McCubrey JA, May WS, Duronio V, Mufson A. Serine/threonine phosphorylation in cytokine signal transduction. Leukemia 2000; 14:9-21.
16. McCubrey JA, Steelman LS, Moye PW, Hoyle PE, Weinstein-Oppenheimer C, Chang F, et al. Effects of deregulated Raf and MEK1 expression on the cytokine-dependency of hematopoietic cells. Adv. Enzyme Regl. 2000; 40:305-37.
17. Blalock WL, Moye PW, Chang F, Pearce M, Steelman LS, McMahon M, et al. Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine-dependency of human and murine hematopoietic cells. Leukemia 2000; 14:1080-96. (Pubitemid 30389513)
18. Moye PW, Blalock WL, Hoyle PE, Chang F, Franklin RA, Weinstein- Oppenheimer C, et al. Synergy between Raf and BCL2 in abrogating the cytokine-dependency of hematopoietic cells. Leukemia 2000; 14:1060-79. (Pubitemid 30389512)
19. Weinstein-Oppenheimer C, Steelman LS, Algate PA, Blalock WL, Burrows C, Hoyle PE, et al. Effects of deregulated Raf activation on integrin, cytokine-receptor expression and the induction of apoptosis in hematopoietic cells. Leukemia 2000; 14:1921-38.
20. Franklin RA, McCubrey JA. Kinases: positive and negative regulators of apoptosis. Leukemia 2000; 14:2019-34. (Pubitemid 32042239)
21. McCubrey JA, Steelman LS, Blalock WL, Lee JT, Moye PW, Chang F, et al. Synergistic effects of PI3K/Akt on abrogation of cytokine-dependency induced by oncogenic Raf. Adv Enzyme Regl 2001; 41:289-323.
22. Blalock WL, Pearce M, Chang F, Lee JT, Pohnert SC, Burrows C, et al. Effects of inducible MEK1 activation on the cytokine-dependency of lymphoid cells. Leukemia 2001; 15:794-807. (Pubitemid 32492703)
23. Kiser M, McCubrey JA, Steelman LS, Shelton JG, Ramage J, Alexander RL, et al. Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed mice. Leukemia 2001; 15:814-18. (Pubitemid 32492705)
24. McCubrey JA, Wang XY, Algate PA, Blalock WL, Steelman LS. Autocrine transformation: cytokine model. In: Blagosklonny MV, ed. Cell Cycle Checkpoints and Cancer. Georgetown, TX: Landes Bioscience 2001:1-16.
25. McCubrey JA, Blalock WL, Chang F, Steelman LS, Pohnert SC, Navolanic PM, et al. Signal transduction pathways: cytokine model In: Blagosklonny MV, ed. Cell Cycle Checkpoints and Cancer. Georgetown, TX: Landes Bioscience 2001:17-53.
26. White MK, McCubrey JA. Suppression of apoptosis: role in cell growth and neoplasia. Leukemia 2001; 1011-21. (Pubitemid 32717269)
27. Chang F, McCubrey JA. p21Cip1 induced by Raf is associated with increased Cdk4 activity in hematopoietic cells. Oncogene 2001; 4353-64.
28. McCubrey JA, Lee JT, Steelman LS, Blalock WL, Moye PW, Chang F, et al. Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells. Cancer Detect Prev 2001; 25:375-93.
29. Sahl B, Marotta A, Matthewson C, Ahluwalia M, Flint J, Owen D, et al. Investigation of the MEK-MAP kinase-Rsk pathway in human breast cancer. Anticancer Res 1999; 19:731-40. (Pubitemid 29168324)
30. Reuter CW, Catling AD, Jelinek T, Weber MJ. Biochemical analysis of MEK activation in NIH-3T3 fibroblasts. Indentification of B-Raf and other activators. J Biol Chem 1995; 270:7644-55.
31. Sivaraman VS, Wang H, Nuovo GJ, Malbon CC. Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 1997; 99:1478-83. (Pubitemid 27163797)
32. Jaiswal RK, Moodie SA, Wolfman A, Landreth GE. The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21Ras. Mol Cell Biol 1994; 14:6944-53.
33. Maemura M, Iino Y, Koibuchi Y, Yokoe T, Morishita Y. Mitogen-activated protein kinase cascade in breast cancer. Oncology 1999; 57:37-44. (Pubitemid 29494883)
34. Fabian JR, Daar IO, Morrison DK. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol Cell Biol 1993; 13:7170-9. (Pubitemid 23321169)
35. Marais R, Light Y, Paterson HF, Marshall CJ. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J 1995; 14:101-10.
36. Eychene A, Dusanter-Fourt I, Barnier JV, Papin C, Charon M, Gisselbrecht S, et al. Expression and activation of B-Raf kinase isoforms in human and murine leukemia cell lines. Oncogene. 1995; 10:1159-65.
37. Pritchard CA, Bolin L, Slattery R, Murray R, McMahon M. Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase. Curr Biol 1996; 6:614-17. (Pubitemid 126656319)
38. Wojnowski L, Zimmer AM, Beck TW, Hahn H, Bernal R, Rapp UR, et al. Endothelial apoptosis in B-Raf-deficient mice. Nature Gen 1997; 16:293-7.
39. Mikula M, Schreiber M, Husak Z, Kucerova L, Ruth J, Wieser R, et al Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J 2001; 20:1952-62. (Pubitemid 32397397)
40. Hagemann C, Rapp UR. Isotype-specific functions of Raf kinases. Exp Cell Res 1999; 253:34-46.
41. Lee JT, McCubrey JA. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention. Leukemia 2002; 16:486-507. (Pubitemid 34449728)
42. Steelman LS, Blalock WL, Wang XY, Moye PW, Lee JT, et al. Elucidation of signal transduction pathways by retroviral infection of cells wih modified oncogenes. In: Terrain DM, ed. Cancer Cell Signaling. Totowa NJ: Humana Press: In press.
43. Wolman S, Heppner G, Wolman E. New directions in breast cancer research. FASEB J 1997; 11:535-43.
44. Maemura M, Iino Y, Koibuchi Y, Yokoe T, Morishita Y. Mitogen-activated protein kinase cascade in breast cancer. Oncology 1999; 57:37-44. (Pubitemid 29494883)
45. Truchet I, Jozan S, Guerrin M, Mazzolini M, Vidal S, Valette A. Interconnections between E2-dependent regulation of cell cycle progression and apoptosis in MCF-7 tumors growing in nude mice. Exp Cell Res 2000; 254:241-8. (Pubitemid 30080580)
46. Clark JW, Santos-Moore A, Stevenson LE, Frackelton AR Jr. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway. Int J Cancer 1996; 65:186-91. (Pubitemid 26051681)
47. Schneider SM, Offterdinger M, Huber H, Grunt TW. Involvement of nuclear steroid/ thyroid/retinoid receptors and protein kinases in the regulation of growth and of c-erbB and retinoic acid receptor expression in MCF-7 breast cancer cells. Breast Cancer Res Treat 1999; 58:171-81. (Pubitemid 30032490)
48. Gehm BD, McAndrews JM, Jordan VC, Jameson JL. EGF activates highly selective estrogen- responsive plasmids by an ER-independent pathway. Mol Cell Endocrinol 2000; 159:53-62. (Pubitemid 30067640)
49. Surmacz E. Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia 2000; 5:95-105.
50. Molloy CA, May FE, Westley BR. Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. J Biol Chem 2000; 275:12565-71. (Pubitemid 30241403)
51. Migliaccio A, Pagano M, Auricchio F. Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene 1993; 8:2183-91. (Pubitemid 23226952)
52. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996; 15:1292-300.
53. Endoh H, Sasaki H, Maruyama K, Takeyama K, Waga I, Shimizu T, et al. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun 1997; 235:99-102. (Pubitemid 27302692)
54. Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa DM. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signaling cascade and c-fos immediate early gene transcription. Endocrinology 1997; 138:4030-3. (Pubitemid 27351961)
55. Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA 1999; 96:4686-96.
56. Castoria G, Barone MV, Di Domenico M, Bilancio A, Ametrano D, Migliaccio A, et al. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J 1999; 18:2500-10. (Pubitemid 29213282)
57. Nuedling S, Kahlert S, Loebbert K, Meyer R, Vetter H, Grohe C. Differential effects of 17beta-estradiol on mitogen-activated protein kinase pathways in rat cardiomyocytes. FEBS Lett 1999; 454:271-276. (Pubitemid 29304614)
58. Lobenhofer EK, Huper G, Iglehart JD, Marks JR. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ 2000; 11:99-110. (Pubitemid 30131490)
59. Pethe V, Shekhar PV. Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron1 of the c-Ha-ras gene. J Biol Chem 1999; 274:30969-78.
60. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH Kinase Nature 2000; 407:538-41.
61. Hisamoto K, Ohmich M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, et al. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 2001; 276:3459-3467.
62. Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, et al. Phosphatidylinositol- 3-OH kinase (PI3K)/AKT2, activated in breast cancer regulates and is induced by estrogen receptorestrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K Cancer Research 2001; 61:5985-91.
63. Wick MJ, Dong LQ, Riojas RA, Ramos FJ, Liu F. Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3'phosphoinositide-dependent protein kinase 1. J Biol Chem 2000; 275:40400-6. (Pubitemid 32064675)
64. Levenson AS, Jordan C. MCF-7:the first hormone-responsive breast cancer cell line. Cancer Res 1997; 57:3071-8. (Pubitemid 27351713)
65. Steelman LS, Algate PA, Blalock WL, Wang XY, Prevost KD, Hoyle PE, et al. Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells. Leukemia 1996; 10:528-42. (Pubitemid 26128795)
66. McCubrey J, Holland G, McKearn J, Risser R. Abrogation of factor-dependence in 2 IL-3-dependent cell lines can occur by two distinct mechanisms. Oncogene Res 1989; 4:97-109. (Pubitemid 19121771)
67. McCubrey JA, Smith SR, Algate PA, DeVente JE, White MK, Steelman LS. Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene. Oncogene 1993; 8:2905-15. (Pubitemid 23312893)
68. Schwartz RC, Stanton LW, Riley SC, Marcu KB, Witte ON. Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol Cell Biol 1986; 6:3321-31.
69. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, et al. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 1999; 286:1738-41. (Pubitemid 129515881)
70. Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (Protein Kinase B). Science 1999; 286:1741-4. (Pubitemid 129515882)
71. Guan K, Figueroa C, Brtva TR, ZhuT, Taylor J, Barber TD, et al. Negative regulation of the serine/threonine kinase B-Raf by Akt. J. Biol. Chem. 2000; 275:27354-9.
72. Salomon DS, Normanno N, Ciardiello F, Brandt R, Shoyab M, Todaro GJ. The role of amphiregulin in breast cancer. Breast Cancer Res Treat 1995; 33:103-14.
73. Martinez-Lacaci I, Saceda M, Plowman GD, Johnson GR, Normanno N, Salomon DS, et al. Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. Endocrinology 1995; 136:3983-92.
74. Shoyab M, McDonald VL, Bradley JG, Todaro GJ. Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-17. Proc Natl Acad Sci USA 1988; 85:6528-32.
75. Normanno N, Selvam MP, Qi CF, Saeki T, Johnson G, Kim N, et al. Amphiregulin as an autocrine growth factor for Ha-ras-and c-erbB-2- transformed human mammary epithelial cells. Proc Natl Acad Sci USA 1994; 91:2790-4.